First Time Loading...
S

Shanghai OPM Biosciences Co Ltd
SSE:688293

Watchlist Manager
Shanghai OPM Biosciences Co Ltd
SSE:688293
Watchlist
Price: 33.35 CNY 2.68% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Shanghai OPM Biosciences Co Ltd

Wall Street analysts forecast Shanghai OPM Biosciences Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai OPM Biosciences Co Ltd is 52.57 CNY with a low forecast of 52.06 CNY and a high forecast of 54.12 CNY.

Lowest Forecast
Wall Street Target
52.06 CNY
56% Upside
Average Forecast
Wall Street Target
52.57 CNY
58% Upside
Highest Forecast
Wall Street Target
54.12 CNY
62% Upside
Lowest
Price Target
52.06 CNY
56% Upside
Average
Price Target
52.57 CNY
58% Upside
Highest
Price Target
54.12 CNY
62% Upside
Shanghai OPM Biosciences Co Ltd Competitors:
Price Targets
B
BLRX
BioLine RX Ltd
82% Downside
DNLI
Denali Therapeutics Inc
172% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
41% Upside
L
084650
Labgenomics Co Ltd
88% Upside
B
BLRX
BioLine RX Ltd
82% Downside
DNLI
Denali Therapeutics Inc
172% Upside
S
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
41% Upside
L
084650
Labgenomics Co Ltd
88% Upside
302440
SK Bioscience Co Ltd
4% Downside
T
1875
TOT BIOPHARM International Co Ltd
131% Upside
GRTS
Gritstone bio Inc
588% Upside
Z
ZURA
Zura Bio Ltd
279% Upside

Revenue
Forecast

Revenue Estimate
Shanghai OPM Biosciences Co Ltd

For the last 3 years the compound annual growth rate for Shanghai OPM Biosciences Co Ltd's revenue is 71%. The projected CAGR for the next 3 years is 25%.

71%
Past Growth
25%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Shanghai OPM Biosciences Co Ltd

The compound annual growth rate of Shanghai OPM Biosciences Co Ltd's operating income for the next 3 years is 19%.

N/A
Past Growth
19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Shanghai OPM Biosciences Co Ltd

The compound annual growth rate of Shanghai OPM Biosciences Co Ltd's net income for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai OPM Biosciences Co Ltd's stock price target?
Price Target
52.57 CNY

According to Wall Street analysts, the average 1-year price target for Shanghai OPM Biosciences Co Ltd is 52.57 CNY with a low forecast of 52.06 CNY and a high forecast of 54.12 CNY.

What is Shanghai OPM Biosciences Co Ltd's Revenue forecast?
Projected CAGR
25%

For the last 3 years the compound annual growth rate for Shanghai OPM Biosciences Co Ltd's revenue is 71%. The projected CAGR for the next 3 years is 25%.

What is Shanghai OPM Biosciences Co Ltd's Operating Income forecast?
Projected CAGR
19%

The compound annual growth rate of Shanghai OPM Biosciences Co Ltd's operating income for the next 3 years is 19%.

What is Shanghai OPM Biosciences Co Ltd's Net Income forecast?
Projected CAGR
24%

The compound annual growth rate of Shanghai OPM Biosciences Co Ltd's net income for the next 3 years is 24%.

ALPHA SPREAD
Join more than 132,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.